APYX Apyx Medical Corp
Price (delayed)
$1.26
Market cap
$47.62M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.66
Enterprise value
$54.64M
Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people's lives through innovative products in the cosmetic and surgical markets. Known for its innovative Helium
Highlights
APYX's equity is down by 47% year-on-year but it is up by 29% since the previous quarter
APYX's net income is down by 25% year-on-year but it is up by 18% since the previous quarter
Apyx Medical's gross profit has decreased by 13% YoY
The revenue has declined by 8% year-on-year
Key stats
What are the main financial stats of APYX
Market
Valuations
Earnings
Shares outstanding
37.79M
Market cap
$47.62M
Enterprise value
$54.64M
Price to earnings (P/E)
N/A
Price to book (P/B)
3.07
Price to sales (P/S)
0.93
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.14
Revenue
$48.1M
Gross profit
$29.36M
Operating income
-$18.85M
Net income
-$23.46M
EBIT
-$17.3M
EBITDA
-$16.59M
Free cash flow
-$18.77M
Per share
Balance sheet
Liquidity
EPS
-$0.66
EPS diluted
-$0.66
Free cash flow per share
-$0.53
Book value per share
$0.41
Revenue per share
$1.35
TBVPS
$1.82
Total assets
$64.84M
Total liabilities
$50.51M
Debt
$38.76M
Equity
$14.21M
Working capital
$45.72M
Debt to equity
2.73
Current ratio
5.26
Quick ratio
4.4
Net debt/EBITDA
-0.42
Margins
Efficiency
Dividend
EBITDA margin
-34.5%
Gross margin
61%
Net margin
-48.8%
Operating margin
-39.2%
Return on assets
-35.9%
Return on equity
-155.8%
Return on invested capital
-28.2%
Return on capital employed
-32%
Return on sales
-36%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
APYX stock price
How has the Apyx Medical stock price performed over time
Intraday
8.62%
1 week
26%
1 month
-16.56%
1 year
-4.55%
YTD
-20.25%
QTD
-20.25%
Financial performance
How have Apyx Medical's revenue and profit performed over time
Revenue
$48.1M
Gross profit
$29.36M
Operating income
-$18.85M
Net income
-$23.46M
Gross margin
61%
Net margin
-48.8%
APYX's net margin is down by 37% YoY but it is up by 17% QoQ
APYX's net income is down by 25% year-on-year but it is up by 18% since the previous quarter
Apyx Medical's gross profit has decreased by 13% YoY
APYX's operating income is up by 13% since the previous quarter and by 6% year-on-year
Growth
What is Apyx Medical's growth rate over time
Valuation
What is Apyx Medical stock price valuation
P/E
N/A
P/B
3.07
P/S
0.93
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.14
The EPS has declined by 22% year-on-year but it rose by 20% since the previous quarter
APYX's equity is down by 47% year-on-year but it is up by 29% since the previous quarter
The price to book (P/B) is 25% lower than the 5-year quarterly average of 4.1 and 7% lower than the last 4 quarters average of 3.3
The stock's price to sales (P/S) is 80% less than its 5-year quarterly average of 4.7 and 7% less than its last 4 quarters average of 1.0
The revenue has declined by 8% year-on-year
Efficiency
How efficient is Apyx Medical business performance
Apyx Medical's return on equity has shrunk by 176% YoY
The return on invested capital is up by 34% year-on-year and by 24% since the previous quarter
The company's return on assets fell by 24% YoY but it rose by 13% QoQ
The return on sales rose by 23% since the previous quarter
Dividends
What is APYX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for APYX.
Financial health
How did Apyx Medical financials performed over time
The total assets is 28% more than the total liabilities
The total assets has contracted by 18% YoY but it has grown by 7% from the previous quarter
Apyx Medical's current ratio has decreased by 4.7% YoY and by 3.7% from the previous quarter
APYX's debt is 173% higher than its equity
The company's debt to equity has surged by 90% YoY but it fell by 22% QoQ
APYX's equity is down by 47% year-on-year but it is up by 29% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.